Previous studies in T1D model by streptozotocin injection in apolipoprotein E-deficient mice have proved that NBD peptide administration ameliorates diabetic kidney damage and atherosclerosis through the modulation of systemic and local inflammation [29]. This evidence concerns the gene APOE and atherosclerosis.